摘要:
An oxime ester compound of formula (I) useful as a photopolymerization initiator. A photopolymerization initiator having the oxime ester compound as an active ingredient is activated through efficient absorption of light of long wavelength, e.g., 405 nm or 365 nm, to exhibit high sensitivity.
In formula (I), R 1 and R 2 are each R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 , or CN; R 11 , R 12 , and R 13 are each hydrogen, a C1-C20 alkyl group, C6-C30 aryl group, a C7-C30 arylalkyl group, or a C2-C20 heterocyclic group; R 3 and R 4 are each R 11 , OR 11 , SR 11 , COR 11 , CONR 12 R 13 , NR 12 COR 11 , OCOR 11 , COOR 11 , SCOR 11 , OCSR 11 , COSR 11 , CSOR 11 , CN, halogen, or a hydroxyl group; a and b is each 0 to 4; X is oxygen, sulfur, selenium, CR 31 R 32 , CO, NR 33 , or PR 34 ; and R 31 , R 32 , R 33 , and R 34 each have the same meaning as R 1 .
摘要:
Oxime carboxylic acid derivatives having the formula I wherein n is either 1 or 0, X represents O or N, R 2 and R 3 represent any rests of an oxime R 2 R 3 NOH and R 1 represents a substituted or unsubstituted, branched or unbranched alkyl-, alkenyl-,akinyl-, cycloalkyl-, cycloalkenyl-, alkoxyalkyl-, aryloxyaryl-, alkoxyaryl-, aryloxyalkyl- or aromatic radical, preferably with 1 to 30 C atoms, or X n R 1 represents are useful as precursors for the delivery of organoleptic compounds, especially for flavors, fragrances and masking agents, and/or antimicrobial compounds.
摘要:
The invention concerns compounds of the formula wherein R is C₃₋₇ alkyl, C₃₋₇ cycloalkyl,
R¹ is hydrogen, lower alkyl or a is 1-3; b is 1-3; c is 0-2; X, Y and Z are each independently, a bond, O, S or NH, with the proviso that if one of X or Y is O, S or NH, the other must be a bond; R² is amino, loweralkylamino, arylamino, loweralkoxy or aryloxy; R³ and R 3′ are independently is hydrogen, halo, hydroxy, lower alkoxy, aryloxy, loweralkanoyloxy, amino, lower alkylamino, arylamino or loweralkanoylamino; R⁴ and R⁵ are each independently hydrogen or lower alkyl; m is 0-4; n is 1-4; and o is 1-4, and oxime and ketone intermediates thereto. The compounds of formula I selectively inhibit an isoenzyme of 3′:5′-cyclic AMP phosphodiesterase located in pulmonary smooth muscle tissue and inflammatory cells and are bronchodilatory or anti-inflammatory and so are useful in the treatment of acute and chronic bronchial asthma as associated pathologies.
摘要翻译:本发明涉及式CHEM的化合物,其中R是C 3-7烷基,C 3-7环烷基,CH 2 CH 2是氢,低级烷基或者CH 2是1-3; b为1-3; c为0-2; X,Y和Z各自独立地为键,O,S或NH,条件是如果X或Y中的一个为O,S或NH,则另一个必须为键; R 2是氨基,低级烷基氨基,芳基氨基,低级烷氧基或芳氧基; R 3和R 3分别独立地是氢,卤素,羟基,低级烷氧基,芳氧基,低级烷酰氧基,氨基,低级烷基氨基,芳基氨基或低级烷酰基氨基; R 4和R 5各自独立地为氢或低级烷基; m为0-4; n为1-4; 和o为1-4,肟和酮为中间体。 式I化合物选择性抑制位于肺平滑肌组织和炎性细胞中的3分钟:5分钟环AMP磷酸二酯酶的同工酶,并且是支气管扩张或抗炎的,因此可用于治疗急性和慢性支气管哮喘,如相关 病症。
摘要:
The present invention relates to compounds having a 1,4-benzoquinone or 1,4-benzoquinone imine scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said 1,4-benzoquinone or 1,4-benzoquinone imine compounds can be used for prophylaxis and/or treatment of cancer and for prophylaxis and/or treatment of inflammatory diseases.